|
H3F3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.573200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.342200E-03 |
| Normal-vs-Stage2 |
4.385200E-04 |
| Normal-vs-Stage3 |
1.193210E-04 |
| Normal-vs-Stage4 |
6.45799999999808E-05 |
| Stage1-vs-Stage2 |
1.184760E-01 |
| Stage1-vs-Stage3 |
7.577100E-03 |
| Stage1-vs-Stage4 |
1.502470E-03 |
| Stage2-vs-Stage3 |
7.208800E-01 |
| Stage2-vs-Stage4 |
5.226600E-01 |
| Stage3-vs-Stage4 |
6.816600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.000500E-04 |
| Normal-vs-AfricanAmerican |
1.532270E-02 |
| Normal-vs-Asian |
6.526300E-02 |
| Caucasian-vs-AfricanAmerican |
7.629600E-02 |
| Caucasian-vs-Asian |
2.861600E-01 |
| AfricanAmerican-vs-Asian |
9.054200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.615280E-04 |
| Normal-vs-Female |
3.263600E-03 |
| Male-vs-Female |
2.222000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.459300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.608500E-04 |
| Normal-vs-Age(61-80Yrs) |
5.981700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.938400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.093400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.950600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.434800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.824400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.753000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.013200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.973210E-01 |
| Normal-vs-Grade 2 |
7.998700E-03 |
| Normal-vs-Grade 3 |
2.48669999999285E-05 |
| Normal-vs-Grade 4 |
8.02659999999955E-05 |
| Grade 1-vs-Grade 2 |
2.421000E-01 |
| Grade 1-vs-Grade 3 |
1.988150E-04 |
| Grade 1-vs-Grade 4 |
4.341900E-03 |
| Grade 2-vs-Grade 3 |
2.57330001751654E-09 |
| Grade 2-vs-Grade 4 |
3.042200E-04 |
| Grade 3-vs-Grade 4 |
7.424400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.119300E-03 |
| Normal-vs-ccB subtype |
1.209570E-04 |
| ccA subtype-vs-ccB subtype |
7.618400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.418900E-04 |
| Normal-vs-N1 |
5.557800E-03 |
| N0-vs-N1 |
9.698000E-01 |
|
|
